Matches 1 - 50 out of 149 1 2 3 >


Match Document Document Title
DE102017201713A1 Composition with amino acids  
The composition contains an amino acid moiety having at least one amino acid, a polysaccharide moiety having at least one non-digestible or poorly digestible polysaccharide, and optionally one or...
DE102016125955A1 Polysaccharide for adaptation of immunity, aging inhibition and improvement of brain activity  
The present invention relates to a polysaccharide for adapting immunity, inhibiting aging and improving brain activity, the production method of which comprises the following steps: Step (100):...
DE202018101105U1 Hygienic agent with active ingredient for lowering the pH of the vagina and / or the external genitals  
The hygienic agent (1) having an active substance for lowering the pH of the vagina and / or the external genitalia, where the active substance contains the crystalline lactic acid or its salts...
DE102016208567A1 Polymer solution for viscous supplementation  
A polymer solution for viscosupplementation is proposed. The polymer solution contains at least one at least partially water-soluble polysaccharide or polysaccharide derivative, a water-soluble...
DE102015226456A1 Process for the sterilization of aqueous polysaccharide solutions and sterile aqueous polysaccharide solutions  
Since polysaccharides can not be sterilized by sterile filtration due to the high viscosity of their aqueous solutions, they are generally sterilized by means of gamma radiation or steam, but this...
DE102015014699A1 A dialysis solution containing at least one osmotic agent  
The invention relates to a dialysis solution having at least one osmotic agent, the osmotic being a polysaccharide modified with 2-sulfoethyl groups.
DE19861497B3 Babies' food and their use for the promotion of human colorectal flora  
According to the invention, baby food containing at least two different, soluble carbohydrates is provided. This baby food is characterized by the fact that the carbohydrates consist of a...
DE19861508A1 Kohlenhydratmischung  
Erfindungsgemäß wird eine Kohlenhydratmischung für diätetische Nahrungen und Pharmazeutika enthaltend mindestens zwei unterschiedliche, lösliche Kohlenhydrate zur Verfügung gestellt. Diese...
DE202016102800U1 Plasma substitute solution  
Plasma replacement solution that receives hydroxyethyl starch and electrolytes, characterized in that, in the following component ratio as the electrolyte it contains sodium fumarate: 58-62...
DE202013012287U1 Gel-forming system for the removal of kidney stone fragments  
Gel-forming composition comprising a composition (A) containing one or more cationically curable polymers, and a composition (B) containing one or more crosslinking agent for crosslinking the...
DE202013012275U1 Kit for producing a cross-linked gel for enclosing kidney stones and / or kidney stone fragments  
A kit for preparing a crosslinked gel for partially or completely surrounding kidney stone fragments, wherein the crosslinked gel is adapted to bind kidney stones and / or kidney stone fragments,...
DE102013022109A1 Oligo (2-7) -Glucuronat comprehensive drug (second medical indication)  
The invention relates to a medicament for oral administration, the oligomers (2-7) -Galacturonsäure, for use in a method for treating or preventing bacterial infections of the gastrointestinal...
DE202014007409U1 Nose cream against Schnarchgeräuche  
Using known per se, at room temperature gel, mixtures of substantially saturated hydrocarbons for the prophylaxis of Schnarchgeräuche, especially atopic rhinitis of the type "Schnarchgeräuche" The...
DE102012021237A1 Substance as mixture of natural substances, useful for combating unicellular parasites in humans and animals, includes drug of natural origin from class of isoquinoline alkaloids, eugenol, and diterpenes of Cassan or non-Cassan type  
Substance comprises a drug of natural origin from the class of isoquinoline alkaloids, eugenol, diterpenes of Cassan or non-Cassan type, and acemannan in the preparation as biogenic quantum dots....
DE102013000699A1 Pharmaceutical composition, useful for topical treatment of hoarseness/inflammatory diseases of mouth and throat, comprises virustatisches or antiviral polysaccharide, and acidic glycosaminoglycan, preferably hyaluronic acid  
Pharmaceutical composition comprises (a) at least one polysaccharide, preferably a virustatisches or antiviral polysaccharide, and (b) at least one acidic glycosaminoglycan or its salt or...
DE102012019029A1 Pharmaceutical formulation prepared by dissolving adjuvant in polyethylene glycols, useful for administration of active multiple charged anions e.g. heparin or its derivative, oligosaccharide or polysaccharide and nucleic acid sequence  
Oral pharmaceutical formulation prepared by dissolving an adjuvant in polyethylene glycols or their derivatives, is claimed.
DE202013000445U1 Composition, in particular pharmaceutical composition, particularly for administration to hoarseness  
Composition, in particular pharmaceutical composition, preferably, in the form of a solid or liquid, preferably solid dosage, in particular for the topical treatment of hoarseness and / or...
DE202012104114U1 Tablet obesitaskontrollierenden ingredients  
Tablet with obesity-controlling ingredients (1), comprising a plurality of active particles (10) having a controlling obesity ingredient; a food additive layer (20), the diemehrfachen active...
DE102012002428A1 Therapy-infusion solution, preferably e.g. macular degeneration therapy-infusion solution, polyneuropathy therapy-infusion solution and Parkinson's therapy-infusion solution, comprises hydroxyethyl acid based solution and Ginkgo biloba  
Therapy-infusion solution, preferably macular degeneration therapy-infusion solution, polyneuropathy therapy-infusion solution, Parkinson's therapy-infusion solution, multiple sclerosis...
DE102010012183A1 Esterified polysaccharide osmotics  
The present invention relates to esterified Polysaccharidosmotika, their use, processes for their preparation as well as compositions containing them.
DE102010012179A1 A device for peritoneal dialysis  
The present invention relates to a device comprising a bag of a semi-permeable membrane, and this device for use in peritoneal dialysis (2).
DE102009037514A1 Water-soluble polysaccharide and their use  
If polysaccharide ethers for ophthalmology and other medical purposes should the ability to form viscoelastic solutions, are improved. This was achieved through the creation of water-soluble...
DE102009029717A1 Medical product, useful for post-surgical adhesion prophylaxis and/or hemostasis, comprises physically crosslinked polyvinyl alcohol and at least one biocompatible nucleating agent  
Medical product comprises physically crosslinked polyvinyl alcohol and at least one biocompatible nucleating agent. An independent claim is included for method for producing the medical product...
DE102008020797A1 Skin cream useful for e.g. treatment and/or prophylaxis of dry skin and/or skin damage in diabetic foot, comprises saccharide e.g. mannobiose, polysaccharide e.g. dextran, multivalent alcohol e.g. glycerol, urea, polycation and carrier  
Skin cream comprises at least one saccharide, at least one polysaccharide, at least one multivalent alcohol, urea, at least one polycation and at least one pharmaceutically or cosmetically...
DE102008020197A1 Quickly wettable, hydrocolloid-containing material, process for its preparation and its use  
The present invention relates to a method for producing a quick-wettable, hydrocolloid-containing material in which a hydrocolloid-containing material is exposed to a plasma.
DE102008005498A1 Adherent, sperm blocking drug combination with contraceptive effect, useful as contraceptive, comprises deionized water, polysaccharide-gum, and alcohol as lubricant, where composition has specific total viscosity  
Adherent, sperm blocking drug combination with contraceptive effect, comprises: pure deionized water; 0.3-10 wt.% of a polysaccharide-gum from cellulose and its derivatives, hemicellulose, fibers,...
DE102008005172A1 Composition, useful for producing an agent for intraoperative application in abdominal cavity to prevent postoperative adhesion, comprises two components of polysaccharide, hyaluronic acid and/or phospholipid, and an antiinflammatory agent  
Composition in form of a solution, comprises at least two components of polysaccharide, hyaluronic acid and/or phospholipid, and an antiinflammatory agent.
DE102007039229A1 Water- and drug-containing gel  
The Invention relates to a hydrogel comprising water, at least one Gelling agent, at least one pharmaceutical active ingredient or cosmetic ingredient and optionally other auxiliaries and...
DE102007037053A1 Haemostatic for surgery minimally invasive  
The Invention relates to a haemostatic device for minimally invasive Operation, especially in the abdomen, in the form of an absorbent Disc (11) of porous biodegradable material with a center and...
DE102007034639A1 Multipart medical  
object of the invention is a multi-part medical device for cleaning wounds that simultaneously supports wound healing by a physiologically occurring System should be supported.
DE102007032662A1 Formulation for protecting skin aging caused by intrinsic or extrinsic factors, and for treating itching skin and atopic eczema, has apiogalacturonan or apiogalacturonan containing extract of Zostera marina and one or multiple hydrocolloids  
The formulation has a content of apiogalacturonan or apiogalacturonan containing extract of Zostera marinaand an additional content of one or multiple hydrocolloids. 0.0001-10, preferably 0.001-5,...
DE102007032664A1 Cosmetic or dermatological preparations for skin care, protection and cleaning, containing apiogalacturonan compounds or extracts thereof from seaweed, together with molecular oxygen  
Preparations containing one or more apiogalacturonans (I) or extract(s) of (I) from Zostera marina and also containing molecular oxygen.
DE102007032663A1 Cosmetic or dermatological preparations for skin care, protection and cleaning, containing apiogalacturonan compounds or extracts thereof from seaweed, together with UV light absorbers  
Preparations containing one or more apiogalacturonans (I) or extract(s) of (I) from Zostera marina and also one or more UV light absorbers.
DE102007032661A1 Cosmetic or dermatological preparations for skin care and cleaning, containing apiogalacturonan compounds or extracts thereof from seaweed, together with emulsifiers  
Preparations containing one or more apiogalacturonans (I) or extract(s) of (I) from Zostera marina and also one or more emulsifiers.
DE102007032660A1 Formulation for use as cosmetic for care and protection of skin from intrinsic or extrinsic aged factor, comprises one or multiple apio galacturonans or one or multiple apio galacturonans having extract of Zostera marina  
The formulation comprises one or multiple apio galacturonans or one or multiple apio galacturonans having extract of Zostera marina and one or multiple mono or polyvalent alcohols. The amount of...
DE60130743T2 MICRO BALLS FOR ACTIVE EMBOLIZATION  
The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are...
DE102006053385B4 Enterococcus faecalis antigen  
Enterococcus faecalis strain type 5 antigen, at least one disaccharide unit comprising, having the following formula: where R1 OH, X = O, Y = O and CA lactyl is.
DE102006053385A1 Enterococcus faecalis and / or Enterococcus faecium antigen  
The This invention relates generally to the field of detection and prevention of infectious diseases caused by Enterococcus faecalis and / or Enterococcus faecium caused. In particular relates to...
DE102005059050A1 Cosmetic-/pharmaceutical composition, useful as hair treatment agent, hair wax or gel wax, and for modeling and/or forming a hairstyle, comprises hydrophobically modified polyol, polysaccharide, emulsifying agent, and fat material  
Cosmetic- or pharmaceutical composition comprises at least one hydrophobically modified polyols (up to 5 wt.%), at least one polysaccharide (up to 5 wt.%), at least one emulsifying agent (up to 25...
DE102005026223A1 Stable hemicellulose paste, process for their preparation and their use  
The Invention relates to a stable uncrosslinked hemicellulose paste and a method for their preparation. The by alkaline extraction Hemicellulose derived from a hemicellulose-containing material is...
DE60118395T2 Pharmaceutical Compositions SUSTAINED RELEASE FOR PARENTERAL APPLICATION OF HYDROPHILIC SUBSTANCES  
Stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions (w/o), for the sustained release by parenteral administration of active ingredients which are...
DE10013539B4 Lipopolysaccharides from Escherichia coli, to processes for their preparation and their uses  
lipopolysaccharide (LPS) from E. coli DSM 6601 of the formula
DE19961182B4 Galactomannan oligosaccharides and processes for their preparation and their use  
process for the production of mannose and galactose-containing oligosaccharides from galactomannans of guar gum, wherein an aqueous solution or suspension of guar gum prepared using a bacteria of...
DE10392417T5 Use of tagatose in laxatives  
process for the manufacture of a laxative, which comprises, as a tagatose to use part.
DE10346833A1 Oligo- und/oder Polysaccharide enthaltende kosmetische oder pharmazeutische Zubereitungen zur Behandlung epithelialen Deckgewebes  
Die vorliegende Erfindung betrifft kosmetische oder pharmazeutische Zubereitungen zur Behandlung epithelialen Deckgewebes, die Oligo- und/oder Polysaccharide als wirksame Bestandteile enthalten,...
DE10339354A1 Synergistic composition for treating metabolic syndrome, comprises swellable or gel-forming satiating and weight reducing agent and hypocholesterolemic and/or antidiabetic agent  
A composition (A) comprising a swellable or gel-forming satiating/weight reducing agent (I) and a hypocholesterolemic and/or antidiabetic agent (II), the ratio of (II) to (I) is 9:1 to 1:9...
DE10321725A1 Enzyme-containing compositions, dietetic foods and pharmaceuticals produced therefrom and their use for medical purposes  
The enzyme-containing compositions comprise one or more hydrolases and one or more antioxidants, acting under antioxidative Vitamins, carotenoids, selenium-containing substances, ubiquinones are...
DE19911053B4 Cosmetic and / or pharmaceutical preparations  
Cosmetic and / or pharmaceutical preparations containing (A) water-soluble β- (1,3) glucans, free from β- (1,6) linkages, and (B) (deoxy) ribonucleic acids and their cleavage and Degradation products.
DE10297369T5 Application of oligosaccharides in cosmetic or dermatological compositions for stimulating the adhesion of keratinocytes to the main proteins of the dermis-epidermis compound and for restoring the Epidermiskohäsion  
application of Oligogalakturonid in cosmetics or for the preparation of a dermatological composition as an agent for stimulating the Adhesion of basal keratinocytes at two major proteins of JDE,...
DE10217356B4 Peritoneal dialysis solution  
Combination of at least two individual solutions for the manufacture of an existing from the individual solutions Solution for peritoneal dialysis, which are brought together by a heat...

Matches 1 - 50 out of 149 1 2 3 >